The C4B gene (Complement Component 4B) encodes a crucial protein in the complement cascade, sharing significant sequence similarity with its close relative C4A while exhibiting distinct biochemical properties and disease associations. Located in the major histocompatibility complex (MHC) class III region on chromosome 6p21.3, C4B is essential for immune defense, inflammation regulation, and increasingly recognized for its role in neurobiology and neurodegenerative diseases[1][2]. Unlike C4A, which preferentially binds amino groups, C4B shows higher affinity for hydroxyl groups on target surfaces, leading to different functional outcomes in complement activation and immune complex handling. Research has revealed important roles for C4B in Alzheimer's disease susceptibility, autoimmune conditions, and neurodevelopmental processes, making it a significant gene for understanding immune-brain interactions in disease.
| Attribute | Value |
|---|---|
| Gene Symbol | C4B |
| Full Name | Complement Component 4B (Chido/Rodgers Blood Group) |
| Chromosomal Location | 6p21.3 (MHC Class III) |
| NCBI Gene ID | 713 |
| OMIM | 120820 |
| Ensembl ID | ENSG00000244731 |
| UniProt ID | P0C0S0 |
| Protein Class | Complement system serine protease |
| Associated Diseases | Alzheimer's Disease, Systemic Lupus Erythematosus, Autism Spectrum Disorder, Multiple Sclerosis |
C4B encodes complement component 4B, a 1741-amino acid zymogen structurally similar to C4A. The protein is composed of three polypeptide chains:
The structural similarity between C4A and C4B (approximately 99% sequence identity in the coding region) reflects their shared evolutionary origin and overlapping functions, yet their distinct thioester reactivity determines their unique roles in immune surveillance and disease pathogenesis.
The key difference between C4A and C4B lies in their thioester chemistry:
This biochemical distinction has important implications for understanding their differential disease associations.
C4B participates in multiple complement activation pathways:
Cleavage products include:
C4B has been increasingly implicated in Alzheimer's disease pathogenesis through several mechanisms:
Elevated C4B expression has been documented in AD brains, particularly in regions affected by amyloid pathology[3]. Studies using proteomic analysis of AD brain tissue have identified significant upregulation of complement components, including C4B, in the prefrontal cortex and hippocampus of AD patients compared to age-matched controls[4].
Key mechanisms include:
Genetic studies have identified associations between C4B variants and AD risk:
The relationship between C4B and AD appears to be complex, with both protective and risk-associated variants identified in different populations.
C4B serves as a critical signal for microglial activation in the AD brain[6]:
In Parkinson's disease, C4B contributes to:
Post-mortem studies show increased C4B expression in the substantia nigra of PD patients, correlating with disease severity[7].
C4B copy number variation has been studied in autism spectrum disorder (ASD):
The relationship between C4B and ASD involves complex gene-environment interactions during critical periods of brain development.
C4A and C4B show opposing roles in multiple sclerosis[8]:
This dichotomy provides valuable insights into complement-mediated neuroinflammation and suggests that targeting specific complement components may have therapeutic value.
C4B, like C4A, is strongly associated with systemic lupus erythematosus:
The complement system is essential for:
C4B variants have been associated with:
C4B is expressed in multiple cell types within the central nervous system:
| Cell Type | Expression Level | Functional Significance |
|---|---|---|
| Microglia | High (increases with activation) | Primary source during neuroinflammation |
| Astrocytes | Moderate | Production during reactive gliosis |
| Neurons | Low | Synaptic localization |
| Endothelial cells | Moderate | Blood-brain barrier function |
C4B is highly expressed in:
C4B contributes to total plasma C4 levels:
The C4B gene shows extensive copy number variation:
Key SNPs in the C4B region:
The C4B gene spans approximately 21 kb and contains:
| Interactor | Interaction Type | Functional Significance |
|---|---|---|
| C1q | Complex formation | Classical pathway initiation |
| C1r | Protease cleavage | Cascade activation |
| C1s | Protease cleavage | C4B processing |
| CR1 (CD35) | Receptor binding | Immune complex clearance |
| CR3 (CD11b/CD18) | Receptor binding | Microglial phagocytosis |
| C3b | C3 convertase component | Amplification loop |
| Properdin | Stabilization | Alternative pathway regulation |
Targeting C4B-mediated pathways represents a therapeutic strategy for:
Clinical trials are evaluating complement inhibitors for:
C4B levels may serve as:
Last updated: 2026-03-26
Sekar A, Bialas AR, de Rivera H, et al. Schizophrenia risk from complex variation of complement component 4. Nature. 2016. ↩︎
Wu T, Sun X, Zhou J, et al. C4 in brain: implications for understanding synaptic remodeling and schizophrenia. Neurochemical Research. 2019. ↩︎
Zhou J, Fang L, Wu J, et al. Complement component 4 is increased in Alzheimer's disease brains. Molecular Neurobiology. 2020. ↩︎
Johnson EC, Carter EK, Dammer EB, et al. Large-scale proteomic analysis of Alzheimer's disease brain identifies altered complement pathway. Acta Neuropathologica Communications. 2019. ↩︎
Lintvedt M, Bø E, Reinvang I, et al. C4B deficiency is associated with increased risk of Alzheimer's disease. Journal of Alzheimer's Disease. 2013. ↩︎
Gomez-Nicola D, Perry VH. Microglial dynamics in Alzheimer's disease. Progress in Brain Research. 2020. ↩︎
Hawkes CA, McLaurin J. Complement activation in Alzheimer's disease: therapeutic targeting. Nature Reviews Neurology. 2023. ↩︎
van Luijn MM, Hageman N, Kummer MP, et al. Opposing roles of C4A and C4B in multiple sclerosis. Nature Reviews Neurology. 2015. ↩︎